The age‐associated disparity of nanocarrier biodistribution limits the nanotherapeutics of childhood solid tumors. This study developed an ultrasound‐activated liposomal prodrug (CSCPTL) to overcome the age‐associated disparity of off‐target distribution.
Danfei Chen +8 more
wiley +1 more source
Dual immunomodulatory and antileishmanial potential of TLR7/8 agonists against <i>Leishmania donovani</i>. [PDF]
Thakur S +6 more
europepmc +1 more source
This study presents a 3D lymphoid tissue model engineered from adipose‐derived stem cells differentiated into fibroblastic reticular cell–like networks and co‐cultured with immune cells. The engineered system successfully generates antigen‐specific antibodies and cytokine responses, providing a platform for studying adaptive immunity, vaccine efficacy,
Mei ElGindi, Shaza Karaman, Jeremy Teo
wiley +1 more source
Therapeutic Antibodies in Hematology: Advances in Malignant and Non-Malignant Disorders. [PDF]
Yasui H, Idogawa M, Ishida T, Imai K.
europepmc +1 more source
Chimeric Antigen Receptor-Macrophage Therapy Enters the Clinic: The First-in-Human Trial for HER2<sup>+</sup> Solid Tumors. [PDF]
Ma W, Jamieson C.
europepmc +1 more source
Genetic engineering and allogeneic optimization of Vδ1 γδ CAR-T cells (ADI-270) for cancer immunotherapy. [PDF]
Liu W, Moriarity BS, Webber BR.
europepmc +1 more source
Impact of IgG monitoring and machine learning based prediction on outcomes of ABO incompatible kidney transplantation in blood type O recipients. [PDF]
Ko Y +8 more
europepmc +1 more source
Oncolytic viruses: Revolutionising the fight against tumours. [PDF]
Zhao Z, Shen Y, Liang T.
europepmc +1 more source
Epigenetic control of antigen presentation failure in osteosarcoma: from single-cell chromatin maps to therapeutic strategies. [PDF]
He Y, Wu H.
europepmc +1 more source

